☰

Beth Levant

Affiliations: 
University of Kansas Medical Center, Kansas City, KS, United States 
Area:
Neuropharmacology
Google:
"Beth Levant"
Mean distance: 16.83 (cluster 6)
 		SNBCP
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Eva King Killam research assistant 1983-1984 UC Davis
Charles B. Nemeroff grad student 1985-2000 Duke
Errol B. DeSouza post-doc 1991-1993

Children

Sign in to add trainee
Gregory N. Bancroft research assistant 1994-1996 University of Kansas Medical Center
Sarah L. Gilliland grad student 1996-1998 University of Kansas Medical Center
Toni L. Richards-Winter grad student 2000-2006 University of Kansas
Michelle R. Healy-Stoffel grad student 2013 University of Kansas
Kristin L. Russell grad student 2013 University of Kansas
Rebecca J. Flietstra post-doc 1996-1996 University of Kansas Medical Center
Rose A. Shafer post-doc 1997-1998 University of Kansas Medical Center
Joy (Tina) A. Ahlgren-Beckendorf post-doc 1998-1999 University of Kansas Medical Center

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Orrù M, Strathman HJ, Floris G, et al. (2020) The adverse effects of pramipexole on probability discounting are not reversed by acute D or D receptor antagonism. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Kaplan SV, Limbocker RA, Levant B, et al. (2018) Regional differences in dopamine release in the R6/2 mouse caudate putamen. Electroanalysis. 30: 1066-1072
Levant B, Healy-Stoffel M. (2018) N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders. Cns & Neurological Disorders Drug Targets
Pes R, Godar SC, Fox AT, et al. (2016) Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release. Neuropharmacology
Chen J, Jiang C, Levant B, et al. (2014) Pramipexole derivatives as potent and selective dopamine D(3) receptor agonists with improved human microsomal stability. Chemmedchem. 9: 2653-60
Healy-Stoffel M, Omar Ahmad S, Stanford JA, et al. (2014) Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat. Brain Research. 1574: 113-9
Chen J, Levant B, Jiang C, et al. (2014) Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists. Journal of Medicinal Chemistry. 57: 4962-8
Russell KL, Berman NE, Gregg PR, et al. (2014) Fish oil improves motor function, limits blood-brain barrier disruption, and reduces Mmp9 gene expression in a rat model of juvenile traumatic brain injury. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 90: 5-11
Russell KL, Berman NE, Levant B. (2013) Low brain DHA content worsens sensorimotor outcomes after TBI and decreases TBI-induced Timp1 expression in juvenile rats. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 89: 97-105
Healy-Stoffel M, Ahmad SO, Stanford JA, et al. (2013) Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats. Neuroscience Letters. 546: 26-30
See more...